About
Eye-tracking-based concussion diagnostic (De Novo 2018); expanded its FDA label to the broadest in the industry (Apr 2025).
HQ: New York, USA
Funding
$8M round (TitletownTech-led); up to $17.95M offering (2024)
—Company profile
EyeBOX — the only baseline-free FDA-authorized eye-tracking aid for concussion diagnosis.
Eye-tracking-based concussion diagnostic (De Novo 2018); expanded its FDA label to the broadest in the industry (Apr 2025).
HQ: New York, USA